Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia.
K MatsudaYozo NakazawaC IwashitaT KurataK HirabayashiS SaitoM TanakaK YoshikawaR YanagisawaK SakashitaS SasakiT HondaK KoikePublished in: Leukemia (2014)